Gastrografin for Malignant Bowel Obstructio

Phase 2

Not yet recruiting

• Conditions: Malignant bowel obstruction; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Cancer - Bowel - Small bowel (duodenum and ileum)

• Registration Number: ACTRN12610001029088
• Lead Sponsor: Ian Bissett

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-11-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Inclusion Criteria
-Age >18 years
-Satisfy criteria for a MBO
-No indication for immediate surgery
-Able to understand the risks/benefits of the study
-Able to give informed written consent
-Any further treatment (surgery, chemotherapy,
radiotherapy, hormone therapy, biological/targeted
therapies) is deemed by relevant practitioners unlikely
to change the acute management of the bowel
obstruction.

Exclusion Criteria

Exclusion Criteria
-Known allergic reaction to study medication or
iodine
-Grossly distended stomach on radiologic exam
-Venting or feeding gastrostomy or jejunostomy
-Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified